Tonix Pharmaceuticals CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury
08:00 EDT 16 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Seth Lederman, M.D., President and CEO of New York City-based Tonix
Pharmaceuticals Holding Corp. (“TONIX” or the “Company”) (OTCBB:TNXP)
says that a good night’s sleep is a potentially powerful, but currently
elusive,...
Other Sources for this Article
Tonix Pharmaceuticals Holding Corp.
Benjamin Selzer,
212-980-9155 x106
Chief Operating Officer
benjamin.selzer@tonixpharma.com
or
LHA
Anne
Marie Fields, 212-838-3777
afields@lhai.com
or
Bruce
Voss, 310-691-7100
bvoss@lhai.com
More From BioPortfolio on "Tonix Pharmaceuticals CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
